Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-067373
Filing Date
2017-12-27
Accepted
2017-12-27 13:33:54
Documents
2
Period of Report
2017-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2669
2 POA DOCUMENT poa.txt EX-24.3_758633 3900
  Complete submission text file 0001209191-17-067373.txt   8009
Mailing Address C/O AMBRX, INC. 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address
Kiener Peter A (Reporting) CIK: 0001328146 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38327 | Film No.: 171275825

Mailing Address 675 W. KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 W. KENDALL STREET CAMBRIDGE MA 02142 617-949-2680
Cue Biopharma, Inc. (Issuer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations